Throughout the year, we distribute a set of Customer Release Notes highlighting updates, new functionality and new features of our RALS systems. These updates can include device interface specific information or on the RALS system as a whole. The list of release notes below are for the most current RALS versions available.
Not sure what version of RALS you are using?
Look on the bottom of the splash screen when you log in, or on any RALS page, click 'Help' (? in the New RALS UI) and then click 'About...'.
RALS System Release Notes:
Version # | Release Date | Release Features | |
7.1.4 | February 3, 2023 | In addition to adding a UDI (Unique Device Identifier) to the “About” dialog within the RALS system, this release corrects issues that occurred in our December 22, 2022 release of Version 7.1.3. Click on the PDF for details. | |
7.1.3 | December 21, 2022 | This release adds 24-hour time (military) format; Ability for users to reset their RALS password; More options for date range filters; Ability to drag, drop and reorder columns; Support for new epoc® GFRckd21 calculation; Support for Gastric pH, Vaginal pH, and Ketone tests in Inform II OTE (Other Test Entry); and much more. | |
7.1.2 | July 15, 2022 | This release adds support for Roche cobas® Liat® C. difficile (CDFA) assay; Levey-Jennings updates including: chart print function, System View “All” is now sorted by “Start Date” rather than by “Last Review Time”, and improved display of accept ranges on the y-axis of the Levey-Jennings chart display; Facility Codes for Locations no longer need to be unique; and more. | |
7.1.1 | March 25, 2022 | With the release of Version 7.1.1, RALS connectivity is now listed in FDA’s Unified Registration and Listing System! Dashboard widgets also can improve day-to-day workflows. | |
7.0.1 | December 15, 2021 | This release contains BD Veritor and Cepheid Xpert Xpress device updates as well as number or RALS system updates. | |
7.0.0 | November 12, 2021 | In this version, POCCs/users do not require Microsoft® Silverlight™ on their desktop; use of Microsoft® Explorer browser not supported; Access RALS using Microsoft® Edge, Mozilla Firefox® and Google® Chrome™ browsers; Other updates include: added support for the Cepheid Xpert® Xpress CoV-2/Flu/RSV plus cartridge; added access to the Abbott i-STAT® DE Configuration; added SIEMENS epoc® reader fields and epoc-specific exports; added 'Linearity', which now provides r & r², and consolidated it under 'Charting' menu with Levey-Jennings. | |
6.0 SP9 Patch 2 | September 16, 2021 | This patch contains corrections for update/upgrade failures as well as connectivity service failures. | |
6.0 SP9 Patch 1 | August 27, 2021 | This patch adds the following support to the BD Veritor® module: Support for the Veritor/Synapsys Triplex (FLU+COVID) assay for Flu A, Flu B and COVID; Displayed in RALS as “BD Flu/CoV2”; Supports patient and QC testing. | |
6.0 SP9 | August 13, 2021 | Includes new device interfacing to the Haemonetics® TEG® 6s analyzer and Haemonetics® TEG® 5000 analyzer; Bi-directional, POCT1A support for the Cepheid® GeneXpert® Xpress; and a wide range of New RALS User Interface page updates. | |
6.0 SP8 | March 25, 2021 | Includes updates for SIEMENS epoc® BG system, Abbott Afinion™ 2 analyzer, Quidel® Triage® System, and Roche Accu-Chek® Inform II device interfaces, file-based Learning Management System support, and RALS eQuiz implementation into the New RALS User Interface, and more. | |
6.0 SP7 | December 14, 2020 | Includes LDAP, Microsoft Active Directory support and a wide range New User Interface updates including a personalized, graphical, textual, and numerical dashboard; Levey-Jennings implementation; Role Management; Result Purge; and Outbound Results Interfacing. | |
6.0 SP6 | April 6, 2020 | Includes COVID-19 support on the Abbott ID NOW analyzer; manual test entry for COVID-19 testing; device interfaces for the Quidel® Solana®, Draeger JM-105, and Nova Stat Profile Prime Plus® | |
6.0 SP5 | February 12, 2020 | Includes New RALS User Interface updates; device module updates; Manual Test Entry (MTE) updates; and more. | |
6.0 SP4 | November | Includes new device interface to the CoaguSense Coag-Sense® PT/INR device; support for the Nova Biomedical NovaNet™ Interface; and more. | |
6.0 SP3 | August 21, 2019 | In this update, we removed the password requirement for every operator in RALS; included a new device interface to the Sysmex XP-300 hematology analyzer; had updates to the Roche Cobas® Liat® system™; and more. | |
6.0 SP2 | May 6, 2019 | Includes new device interfaces to the Cepheid® GeneXpert® Xpress and Hemosonics Quantra®; updates to the Abbott Glucose Module, Afinion™ 2, Cepheid GeneXpert System, SIEMENS epoc® Blood Analysis System, and Manual Test Entry; Secure Device Communication; and much more. | |
6.0 SP1 | December 20, 2018 | Includes a new device interface to the Quidel® Sofia® 2; and Module updates to the Quidel® Sofia®, Quidel® Triage® Meter System, HemoCue® 201 DM Glucose & HB Analyzers and Manual Test Entry (MTE). | |
6.0 | October 31, 2018 | Includes System Rebranding, HealthStream® LMS System Integration, Manual Test Entry (MTE) Additional Test Support, SIEMENS epoc® Blood Analysis System updates, a New “i-STAT® Quality Check Code by Operator Only” report, and much more. |
© 2023 Abbott. All rights reserved. All trademarks referenced are trademarks of either the Abbott group of companies or their respective owners. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott. Any photos displayed are for illustrative purposes only. Any person depicted in such photos is a model.
This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Abbott takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage. Your use of this website and the information contained herein is subject to our Website Terms and Conditions and Privacy Policy. Interest-Based Ads.